Margaret M. Fleming
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Margaret M. Fleming has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Dan MacFarlane
Emory University School of Medicine, Atlanta, Georgia
2 shared publications- Richard Duszak
Chair, Department of Radiology, University of Mississippi Medical Center, Jackson, Mississippi
2 shared publications - Aaron Winkler
Inflammation and Immunology Research Unit, Pfizer Inc., Cambridge, MA, USA
1 shared publication Anna I. Holbrook
Department of Radiology and Imaging Sciences, Winship Cancer Institute, Emory University, 1701 Uppergate Dr, Ste C-1104, Atlanta, GA 30322
1 shared publicationChaejin Kim
Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University and
1 shared publication- Cletus A. Arciero
Department of Surgery Winship Cancer Institute of Emory University Atlanta Georgia USA
1 shared publication
Latest Publications
- 1 July 2019
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 16 (7) , 902-907
Digital Breast Tomosynthesis Implementation: Considerations for Emerging Breast Cancer Screening Bundled Payment Models
- 1 July 2019
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 16 (7) , 902-907
Digital Breast Tomosynthesis Implementation: Considerations for Emerging Breast Cancer Screening Bundled Payment Models
- Open Access
- 1 July 2018
- Published by SAGE Publications in The American Surgeon™
- Vol. 84 (7) , 1133-1137
Are Lymph Node Characteristics on Axillary Ultrasound Associated with ≥3 Positive Lymph Nodes in Patients Managed by the American College of Surgeons Oncology Group Z0011 Trial Criteria?
Patients often receive axillary ultrasound-biopsy (AUS-B) before clinical evaluation. One positive biopsy in the absence of palpable disease rarely indicates additional nodal involvement, but it eliminates patients from being managed by the American College of Surgeons Oncology Group Z0011 trial criteria. To determine which patients may benefit from AUS-B, we analyzed whether characteristics on AUS were associated with large-volume axillary disease and, thus, the need for axillary lymph node (LN) dissection. A retrospective review identified patients who met Z0011 criteria and underwent AUS. Clinicopathologic and ultrasound characteristics were compared between patients with ≤2 versus ≥3 positive LNs. Two hundred and seven patients with cT1-2N0 tumors underwent preoperative AUS and breast-conserving surgery. On multivariate analysis, three AUS combinations were associated with ≥3 positive LNs: cortical thickness (CT) > 4 mm + loss of fatty hilum + round shape (P = 0.0218), CT > 4 mm + loss of fatty hilum (P = 0.0211), and CT > 4 mm + round shape (P = 0.0155). Preoperative axillary LN biopsy in patients with a single abnormal LN characteristic on AUS may be unnecessary because a positive finding will eliminate management according to Z0011 criteria. Cortical thickness >4 mm combined with any other abnormal characteristic was associated with ≥3 positive LNs, supporting the performance of AUS-B in this population.
- 1 July 2018
- Published by SAGE Publications in The American Surgeon™
- Vol. 84 (7) , 1133-1137
Open AccessAre Lymph Node Characteristics on Axillary Ultrasound Associated with ≥3 Positive Lymph Nodes in Patients Managed by the American College of Surgeons Oncology Group Z0011 Trial Criteria?
Patients often receive axillary ultrasound-biopsy (AUS-B) before clinical evaluation. One positive biopsy in the absence of palpable disease rarely indicates additional nodal involvement, but it eliminates patients from being managed by the American College of Surgeons Oncology Group Z0011 trial criteria. To determine which patients may benefit from AUS-B, we analyzed whether characteristics on AUS were associated with large-volume axillary disease and, thus, the need for axillary lymph node (LN) dissection. A retrospective review identified patients who met Z0011 criteria and underwent AUS. Clinicopathologic and ultrasound characteristics were compared between patients with ≤2 versus ≥3 positive LNs. Two hundred and seven patients with cT1-2N0 tumors underwent preoperative AUS and breast-conserving surgery. On multivariate analysis, three AUS combinations were associated with ≥3 positive LNs: cortical thickness (CT) > 4 mm + loss of fatty hilum + round shape (P = 0.0218), CT > 4 mm + loss of fatty hilum (P = 0.0211), and CT > 4 mm + round shape (P = 0.0155). Preoperative axillary LN biopsy in patients with a single abnormal LN characteristic on AUS may be unnecessary because a positive finding will eliminate management according to Z0011 criteria. Cortical thickness >4 mm combined with any other abnormal characteristic was associated with ≥3 positive LNs, supporting the performance of AUS-B in this population.
- Open Access
- 1 November 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (45) , 18689-18698
IRAK4 kinase activity controls Toll-like receptor–induced inflammation through the transcription factor IRF5 in primary human monocytes
- 1 November 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (45) , 18689-18698
Open AccessIRAK4 kinase activity controls Toll-like receptor–induced inflammation through the transcription factor IRF5 in primary human monocytes
- 1 February 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 208 (2) , 267-274
Update on Image-Guided Percutaneous Ablation of Breast Cancer
OBJECTIVE. The purpose of this article is to delineate the potential techniques for percutaneous ablation of breast cancer, discuss the advantages and disadvantages of each technique, and provide results from recent studies on these technologies. The techniques discussed are cryotherapy, laser irradiation, microwave irradiation, radiofrequency ablation, high-intensity focused ultrasound ablation, and irreversible electroporation. CONCLUSION. Although percutaneous ablation techniques have some promising potential for less-invasive treatment of breast cancer, larger multicenter trials are needed to confirm their efficacy, especially in comparison with the reference standard of lumpectomy. The use of these techniques also leads to other remaining unanswered questions, including how to manage the axilla and which patients are the best candidates for these treatments.
- 1 February 2017
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 208 (2) , 267-274
Update on Image-Guided Percutaneous Ablation of Breast Cancer
OBJECTIVE. The purpose of this article is to delineate the potential techniques for percutaneous ablation of breast cancer, discuss the advantages and disadvantages of each technique, and provide results from recent studies on these technologies. The techniques discussed are cryotherapy, laser irradiation, microwave irradiation, radiofrequency ablation, high-intensity focused ultrasound ablation, and irreversible electroporation. CONCLUSION. Although percutaneous ablation techniques have some promising potential for less-invasive treatment of breast cancer, larger multicenter trials are needed to confirm their efficacy, especially in comparison with the reference standard of lumpectomy. The use of these techniques also leads to other remaining unanswered questions, including how to manage the axilla and which patients are the best candidates for these treatments.
- 1 November 2015
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 12 (11) , 1155-1161
Magnitude of Impact, Overall and on Subspecialties, of Transitioning in Radiology from ICD-9 to ICD-10 Codes
- 1 November 2015
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 12 (11) , 1155-1161
Magnitude of Impact, Overall and on Subspecialties, of Transitioning in Radiology from ICD-9 to ICD-10 Codes